EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms
Status
Completed
Conditions
Duodenal Obstruction
Gastric Outlet Obstruction
Treatments
Device: EVOLUTION® Duodenal Stent
Details and patient eligibility
About
The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. It is not the goal to change the usual treatment practice of the investigator or the center, nor to collect information on uses outside the product's indications. Patients will be treated as per usual medical practices.
Enrollment
110 patients
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Patients for whom this device would be chosen in standard practice
Exclusion criteria
- Patients for whom this device would not normally be chosen in standard practice
Trial design
110 participants in 1 patient group
EVOLUTION® Duodenal Stent
Treatment:
Device: EVOLUTION® Duodenal Stent
Trial contacts and locations
6
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems